Hims & Hers Health shows 50% revenue growth, $1B in cash, and 2.4x 2026 sales with strong personalization and GLP-1 sales.

Few people consult a doctor before attempting weight loss. Hims offers virtual weight loss support for men, including consultations and prescriptions. Hims provides GLP-1 injections, meal replacements ...

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, built its growth strategy around a highly scalable, ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. ON THIS PAGE As a 37-year-old man who has seen ...

Hims & Hers is down 30% but still a Buy: margin expansion, GLP-1 clarity, new hormone care, and global growth. Learn more about HIMS stock here.

Results from a new survey of Hims & Hers’ employees has certified the company as a ‘great place to work’ for 2023 SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

(Reuters) -Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some analysts see a need for the online website to adjust to changing ...

Hims & Hers shares plunged earlier this week after Novo Nordisk ended its collaboration with the company. The stock appears to be bouncing back as it nears oversold ...